Healthcare Sector
Market Tracker
15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
| Expires | Type | Strike | OI | Change | Percent |
|---|---|---|---|---|---|
| 06/17/2027 | CALL | $87.50 | 152 | +134 | +744.44% |
| 04/17/2026 | CALL | $95.00 | 1,494 | +109 | +7.87% |
| 01/16/2026 | CALL | $92.50 | 2,738 | +45 | +1.67% |
| 02/20/2026 | CALL | $97.50 | 294 | +28 | +10.53% |
| 06/18/2026 | PUT | $87.50 | 193 | +27 | +16.27% |
| 04/17/2026 | PUT | $90.00 | 1,037 | +25 | +2.47% |
| 01/16/2026 | PUT | $95.00 | 1,467 | -40 | -2.65% |
| 01/16/2026 | CALL | $82.50 | 1,835 | -42 | -2.24% |
| 01/16/2026 | CALL | $95.00 | 3,241 | -59 | -1.79% |
| 04/17/2026 | CALL | $80.00 | 1,401 | -65 | -4.43% |
| 01/16/2026 | CALL | $80.00 | 6,542 | -87 | -1.31% |
| 01/16/2026 | PUT | $97.50 | 0 | -177 | -100.00% |
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
| Name | Pct Held | Shares | Total |
|---|---|---|---|
| Washington Mutual Investors Fund | 1.04% | 27.18M | 1.81B |
| Vanguard/Primecap Fund | 0.99% | 25.87M | 1.72B |
| Vanguard/Wellington Fund Inc. | 0.73% | 19.18M | 1.28B |
| American Mutual Fund Inc | 0.33% | 8.7M | 578.3M |
| Price (T.Rowe) Health Sciences Fund | 0.30% | 8M | 531.71M |
| Invesco ETF Tr-Invesco QQQ Tr, Series 1 ETF | 0.30% | 7.93M | 526.89M |
| Vanguard Fenway Funds-Equity Income Fund | 0.27% | 7.11M | 472.77M |
| Price (T.Rowe) Value Fund | 0.22% | 5.86M | 389.5M |
| Vanguard Fenway Fds-Primecap Core Fund | 0.21% | 5.63M | 374.17M |
| Vanguard/Wellesley Income Fund | 0.20% | 5.28M | 351.09M |
The Newest Stock in the Nasdaq-100 Soared 549,000% Since Its IPO, and It's Still a Buy Right Now, According to Wall Street (Hint: Not Strictly a Tech Company)
01/15 04:02 am
The Motley Fool
Read moreAscentage Pharma Outlined its Global Innovation Strategy During Presentation at 44th Annual J.P. Morgan Healthcare Conference
01/14 09:25 pm
GlobeNewswire Inc.
Read moreGeneralized Myasthenia Gravis Market Outlook Shows Strong Momentum During the Forecast Period (2025–2034) Driven by Novel Immunotherapies | DelveInsight
01/14 02:00 pm
GlobeNewswire Inc.
Read moreHUTCHMED Highlights Publication of Phase III SACHI Results in The Lancet
01/14 12:00 am
GlobeNewswire Inc.
Read more1 Quantum Computing Stock to Buy that Could Soar in 2026
01/13 03:16 pm
The Motley Fool
Read moreSystemic Lupus Erythematosus Market to Exhibit Growth at a CAGR of 9.4% During the Forecast Period (2025–2034) Owing to Rising Use of Biologics – Approvals of BENLYSTA and SAPHNELO, Plus a Strong Pipeline | DelveInsight
01/13 02:00 pm
GlobeNewswire Inc.
Read morePharmacy XD Launches Nationally Licensed Direct-to-Patient Mail Order Pharmacy and Distribution Platform - Headquartered in Florida's Fastest-Growing Healthcare Corridor
01/08 05:30 pm
Benzinga
Read moreAstraZeneca's Self-Injectable Lupus Drug Shines In Late-Stage Trial
01/06 07:43 am
Benzinga
Read moreG-Protein Coupled Receptors (GPCRs) Market Size to Hit USD 6.04 Billion by 2032, Growing at a CAGR of 5.59% - SNS Insider
01/05 11:00 am
GlobeNewswire Inc.
Read moreInvest Outside the U.S. With These Top International ETFs
12/31 03:20 pm
The Motley Fool
Read moreAstraZeneca's Lung Cancer Combo Falls Short In Phase 3 Trial
12/22 01:19 pm
Benzinga
Read moreGSK Expands Use Of Urinary Tract Infection Drug For Gonorrhoea Patients
12/12 12:12 pm
Benzinga
Read moreGestational Diabetes Market to Reach USD 22.58 Billion by 2034, Driven by Rising Awareness and Rapid Innovations
12/11 11:00 am
GlobeNewswire Inc.
Read moreDrugmakers Briefed As Vaccine Skeptics Like RFK Jr. Probe RSV Therapy Risks
12/09 12:30 pm
Benzinga
Read moreAstraZeneca, GSK Among Executives Asked To Help Redesign UK Pricing Rules-Report
12/03 01:24 pm
Benzinga
Read moreAstraZeneca's Hard To Control Hypertension Drug Advances, With FDA Decision Expected In 2026
12/03 11:27 am
Benzinga
Read moreSeasonal Vaccines Market Accelerating Growth and Rising Opportunities Through 2035
12/03 11:00 am
GlobeNewswire Inc.
Read moreVaccine Development Company Landscape Report 2025: Recent Expansions, Partnerships and Collaborations, Big Pharma Initiatives and Cost Price Analysis
12/02 05:37 am
GlobeNewswire Inc.
Read moreGeriatric Care Services Market is expected to generate a revenue of USD 2.03 Billion by 2032, Globally, at 7.98% CAGR: Verified Market Research®
11/27 11:50 pm
GlobeNewswire Inc.
Read moreHER2-positive Gastric Cancer Clinical Trial Pipeline: Insights into a Growing Landscape with 20+ Companies Advancing Novel Treatments| DelveInsight
11/27 02:00 pm
GlobeNewswire Inc.
Read moreAntitumor ADC Drugs Market Forecast Shows Strong 12.86% CAGR Through 2035
11/27 10:00 am
GlobeNewswire Inc.
Read moreHUTCHMED Highlights Clinical Data to be Presented at the 2025 ESMO Asia Congress and the 2025 ASH Annual Meeting
11/26 08:00 pm
GlobeNewswire Inc.
Read moreChronic Heart Failure Clinical Trial Pipeline Shows Potential with Active Contributions from 25+ Key Companies | DelveInsight
11/25 02:00 pm
GlobeNewswire Inc.
Read moreQ3 2025 Contract Research Organization (CRO) Activity and Intel Report Featuring ICON, Astrazeneca, Akesobio, CSPPC Pharmaceutical, ImmunityBio, and Boryung
11/25 10:00 am
GlobeNewswire Inc.
Read moreAstraZeneca Doubles Down On US Biologics Buildout As Drug Discovery Partnership Grows
11/24 01:58 pm
Benzinga
Read moreWhy AstraZeneca Stock Bumped Higher Today
11/21 07:23 pm
The Motley Fool
Read moreBurning Rock Reports Third Quarter 2025 Financial Results
11/20 02:52 am
GlobeNewswire Inc.
Read moreUnnatural Amino Acids Market to Reach US$ 5.03 Billion By 2032 Driven by Advances in Drug Discovery, Biologics and Protein Engineering - SNS Insider
11/11 04:38 am
GlobeNewswire Inc.
Read moreWhy AstraZeneca Stock Was a Winner Today
11/10 06:20 pm
The Motley Fool
Read moreMedera Presents Late-Breaking Data from First-In-Human Gene Therapy Trial for Heart Failure with Preserved Ejection Fraction at American Heart Association Scientific Sessions 2025
11/09 10:00 am
GlobeNewswire Inc.
Read moreEli Lilly, Novo Nordisk Make Weight-Loss Drugs More Affordable Via Medicare, Medicaid, TrumpRx
11/06 03:10 pm
Benzinga
Read moreUp 47%, Should You Buy IonQ Right Now?
10/30 10:20 am
The Motley Fool
Read moreStep Pharma announces the appointment of Dr Karen Smith as Chief Medical Officer
10/28 08:00 am
GlobeNewswire Inc.
Read moreEccogene Eyes Hong Kong IPO With Experimental Weight-Loss Drug, AstraZeneca Partnership
10/23 09:22 am
Benzinga
Read moreSmall Cell Lung Cancer Market Research 2025-2035: Growth Driven by Advancements in Novel Therapies, Including Immunotherapies, Targeted Therapies, and Combination Treatments
10/21 04:41 am
GlobeNewswire Inc.
Read morePrediction: This Unstoppable Vanguard ETF Will Beat the S&P 500 Again in 2026
10/20 04:48 am
The Motley Fool
Read moreMerck's Keytruda Plus Chemo Regimen Shows Overall Survival Benefit In Recurrent Ovarian Cancer Patients
10/16 10:33 am
Benzinga
Read moreEli Lilly's Oral Weight Loss Drug Shows Superiority Over Two Approved Drugs
10/15 01:24 pm
Benzinga
Read moreAstraZeneca Expands Virginia Investment To $4.5 Billion For Cancer, Obesity Drugs
10/09 03:22 pm
Benzinga
Read moreAstraZeneca's Baxdrostat Shows Meaningful Blood Pressure Control In Patients With Resistant Hypertension
10/07 11:40 am
Benzinga
Read moreTheolytics Appoints Experienced Medical Oncologist Matilde Saggese, MD, as Chief Medical Officer
10/07 03:00 am
GlobeNewswire Inc.
Read moreAstraZeneca/Daiichi Sankyo Partnered Breast Cancer Drug Shows Survival Benefit Over Chemotherapy
10/06 08:50 am
Benzinga
Read moreAstraZeneca Stock Is Up 10% on Tariff News. But Is the Pharmaceutical Giant a Buy?
10/02 12:22 pm
The Motley Fool
Read moreAstraZeneca Moves From ADRs To NYSE Listing
09/29 08:25 am
Benzinga
Read moreYour AstraZeneca Medicine Could Be Cheaper As Much As 70%
09/26 01:34 pm
Benzinga
Read moreTrump’s Tariff Gambit: Pharma in the Crosshairs and Global Markets on Edge
09/26 02:54 am
Investing.com
Read moreAdvanced Liver Cancer Clinical Trial Pipeline Shows Potential with Active Contributions from 50+ Key Companies | DelveInsight
09/25 01:00 pm
GlobeNewswire Inc.
Read moreInfluenza Vaccine Market Size to Cross USD 16.73 billion by 2034 at 7.02% CAGR
09/25 11:00 am
GlobeNewswire Inc.
Read moreUnited Kingdom The Worst European Country For Drug Prices: Eli Lilly CEO
09/24 02:15 pm
Benzinga
Read moreBurning Rock's OncoGuide™ OncoScreen™ Plus CDx System Now Approved in Japan as a Companion Diagnostic for Capivasertib in Breast Cancer
09/24 02:42 am
GlobeNewswire Inc.
Read more